How Listeria, Used as a Vaccine, Signals an Immune Response
This article was originally published in Start Up
A lab at the University of California, Berkeley, has identified a small molecule that the microbe Listeria secretes while inside the host cell, which triggers a T cell response and protective immunity. The finding supports the notion that studying interactions of bacteria with the immune system could be useful in vaccine deelopment. It's also good news for the small firm re-started around the use of live, attenuated, recombinant Listeria as an adjuvant/vaccine vector.
You may also be interested in...
A new publication offers up proof of concept that the genetic signatures of microorganisms found in blood and tumor tissue could improve precision medicine cancer diagnostics. The study also bolsters the notion that targeting the microbiome could lead to innovative cancer therapies.
A better understanding of heme trafficking could lead to drug targets in metabolic diseases, anemias, porphyrias, hemolytic diseases such as sickle cell disease – even parasitic infections.
A series of basic research insights around the cell death process called ferroptosis could form the underpinnings of a new class of treatments aimed at drug resistant tumors.